2018-08-10 Bayer announces acceptance of nine abstracts on the use of Xarelto® in patients from a broad range of clinical and real-world studies
2018-07-27 Bayer receives positive CHMP opinion for rivaroxaban for patients with coronary or peripheral artery disease
2018-07-24 Bayer receives approval for Kovaltry® in China for the treatment of children and adults with Hemophilia A
2018-07-09 XANTUS programme confirms low bleeding and low stroke rate with Xarelto® in 11,121 prospectively investigated patients with atrial fibrillation
